38
15.15% (24h)
Sally A1C
A1C
DeSci Protocols in Chronic Diseases
43%
Transparency Score 
$0.1547
5.08% - Trading Volume(24h) 302.33% $1,159.8
- Circulating Market Cap$3,250,003.56 #1494
- FDV$3,250,611
- Circulating Supply21,000,000 A1C
- Total Supply21,000,000 A1C
- All-time High $14.54 (Feb 28, 2025)
- All-time Low $0.146 (Sep 22, 2025)
- Contract Address
0x1f1c...ad69 - Launched Jan 2025
Analytics
Performances
Comparison
Essentials
Details
Event Calendar
Financials
Top Holders
Trade
Open Markets
𝕏 Data
Follow Updates
Follow Lists
Performances
RD Popularity Index
Project Rank: 6005/19040
RD Growth Index
25
0% (24h)
Project Rank: 8034/19040
| 1h | 24h | 7d | 30d | 60d | 90d |
| 0.15% | 5.09% | 3.68% | 28.77% | 47.72% | -- |
Comparison
Total Raised: --
Fundraising not disclosed
FDV: --
Token not listed
24h Trading Volume: --
Token not listed
Project Name
Sally A1C
A1C
Intro
--
Total Raised
--
Core Team
--
Core Investors
--
RD Growth Index (7d %)
--
RD Popularity Index (7d %)
--
Details
Sally A1C is a Web3-integrated protocol combining AI-driven insights with blockchain technology to support metabolic health and chronic disease management. Users access personalized recommendations, upload medical documents for analysis, earn $A1C tokens for premium features, and engage with a holistic health platform.
Event Calendar
2025-01-20
A1C is live for trading
Share to 
Share poster
Share posterTop Holders
Open Markets
--
# | Exchange | Pair | Price | +2% depth | -2% depth | Volume (24h) | volume % |
|---|---|---|---|---|---|---|---|
No Data | |||||||
𝕏 Follow Updates
No Data𝕏 Follow Lists
$0.1547
5.08% - Trading Volume(24h) 302.33% $1,159.8
- Circulating Market Cap$3,250,003.56 #1494
- FDV$3,250,611
- Circulating Supply21,000,000 A1C
- Total Supply21,000,000 A1C
- All-time High $14.54 (Feb 28, 2025)
- All-time Low $0.146 (Sep 22, 2025)
- Contract Address 0x1f1c...ad69
- Launched Jan 2025
Rate Sally A1C
Rated by 0 users
What’s your take on Sally A1C? Share your review.
Reviews and ratings are posted by users, do not constitute financial advice, and do not represent the views of the platform.
